Peggy GANDIA

69
Documents

Présentation

Publications

Publications

Image document

Vancomycin population pharmacokinetic models: Uncovering pharmacodynamic divergence amid clinicobiological resemblance

Peggy Gandia , Sahira Chaiben , Nicolas Fabre , Didier Concordet
CPT: Pharmacometrics and Systems Pharmacology, In press, 14 (1), pp.142-151. ⟨10.1002/psp4.13253⟩
Article dans une revue hal-04817060 v1
Image document

A population pharmacokinetic model for sertraline in women during the perinatal period—A contribution from the ConcePTION project

Anaëlle Monfort , Evelina Cardoso , Chin B Eap , Nicolas Ansermot , Severine Crettol et al.
British Journal of Clinical Pharmacology, 2024, 90 (11), pp.2849-2860. ⟨10.1111/bcp.16177⟩
Article dans une revue hal-04662844 v1
Image document

Hypoalbuminemia and Pharmacokinetics: When the Misunderstanding of a Fundamental Concept Leads to Repeated Errors over Decades

Peggy Gandia , Sarah Decheiver , Manon Picard , Romain Guilhaumou , Sarah Baklouti et al.
Antibiotics, 2023, 12 (3), pp.515. ⟨10.3390/antibiotics12030515⟩
Article dans une revue hal-04061765 v1

Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding: A human lactation study from the ConcePTION project

Hedvig Nordeng , Christine Wegler , Annika Lindqvist , Erik Melander , Mikaela Magnusson et al.
Basic and Clinical Pharmacology and Toxicology, 2023, 134 (1), pp.153-164. ⟨10.1111/bcpt.13948⟩
Article dans une revue hal-04948333 v1
Image document

Exploration of the relationship between cumulative exposure to tobramycin and ototoxicity in patients with cystic fibrosis

Justine Madaule , Félix Valenzuela , Marie Mittaine , Yohan Gallois , Blandine Baladi et al.
Journal of Cystic Fibrosis, 2023, 22 (5), pp.944-948. ⟨10.1016/j.jcf.2023.04.002⟩
Article dans une revue hal-04086358 v1
Image document

“De-Shrinking” EBEs: The Solution for Bayesian Therapeutic Drug Monitoring

Sarah Baklouti , Peggy Gandia , Didier Concordet
Clinical Pharmacokinetics, 2022, 61 (5), pp.749 - 757. ⟨10.1007/s40262-021-01105-y⟩
Article dans une revue hal-03670618 v1
Image document

Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?

Sarah Baklouti , S. Marolleau , P. Chavanet , E. Bonnet , Didier Concordet et al.
Antimicrobial Agents and Chemotherapy, 2022, 66 (1), ⟨10.1128/AAC.01493-21⟩
Article dans une revue hal-03578727 v1

Safety of Pyrazinamide for the Treatment of Tuberculosis in Older Patients Over 75 Years of Age

Stella Rousset , Margaux Lafaurie , Hélène Guet-Revillet , Caroline Protin , Jean Le Grusse et al.
Drugs and Aging, 2021, 38 (1), pp.43-52. ⟨10.1007/s40266-020-00811-9⟩
Article dans une revue hal-03158686 v1

Maraviroc exposure is influenced by exogenous thyrotoxicosis

David Metsu , Christian Aquilina , Pierre Delobel , Peggy Gandia , Frédérique Savagner et al.
AIDS. Official journal of the international AIDS Society, 2021, 35 (4), pp.701-703. ⟨10.1097/QAD.0000000000002754⟩
Article dans une revue hal-03473015 v1
Image document

Neglecting plasma protein binding in COVID-19 patients leads to a wrong interpretation of lopinavir overexposure

Francoise Stanke-Labesque , Didier Concordet , Zoubir Djerada , Stephane Bouchet , Caroline Solas et al.
Clinical Pharmacology and Therapeutics, 2021, Therapeutic Innovations in Infectious Diseases, 109 (4), pp.1030-1033. ⟨10.1002/cpt.2196⟩
Article dans une revue hal-03191652 v1
Image document

Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infection

Midas B Mulder , Robert A Man , Nassim Kamar , Gűlcan Durmaz , Joep Bruijne et al.
Journal of Viral Hepatitis, 2021, 28 (2), pp.431-435. ⟨10.1111/jvh.13432⟩
Article dans une revue hal-03580025 v1
Image document

Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation

Arnaud del Bello , Clotilde Gaible , Nathalie Longlune , Anne-Laure Hebral , Lauren Esposito et al.
Frontiers in Pharmacology, 2021, 12, ⟨10.3389/fphar.2021.602764⟩
Article dans une revue hal-03623073 v1

Efficacy of dihydroartemisinin/piperaquine in patients with noncomplicated Plasmodium falciparum malaria in Yaoundé, Cameroon

Mélissa Mairet-Khedim , Sandrine Nsango , Christelle Ngou , Sandie Menard , Camille Roesch et al.
Journal of Antimicrobial Chemotherapy, 2021, 76 (11), pp.3037-3044. ⟨10.1093/jac/dkab281⟩
Article dans une revue pasteur-03494748 v1
Image document

Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?

Didier Concordet , Peggy Gandia , J L Montastruc , Alain Bousquet‐mélou , P Lees et al.
Clinical Pharmacokinetics, 2020, ⟨10.1007/s40262-019-00848-z⟩
Article dans une revue hal-02627432 v1
Image document

Authors' Reply to Yu et al.: ""Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?

Didier Concordet , Peggy Gandia , Jean-Louis Montastruc , Alain Bousquet‐mélou , Peter Lees et al.
Clinical Pharmacokinetics, 2020, ⟨10.1007/s40262-019-00852-3⟩
Article dans une revue hal-02619187 v1
Image document

Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane/tazobactam: an ex vivo and in vivo study

Camille Mané , Clément Delmas , Jean Porterie , Géraldine Jourdan , Patrick Verwaerde et al.
Journal of Translational Medicine, 2020, 18 (1), pp.213. ⟨10.1186/s12967-020-02381-1⟩
Article dans une revue hal-02940915 v1

Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations

Eloise Baudou , Anne Lespine , Geneviève Durrieu , François André , Peggy Gandia et al.
New England Journal of Medicine, 2020, 383 (8), pp.787--789. ⟨10.1056/NEJMc1917344⟩
Article dans une revue hal-02928174 v1
Image document

Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?

Didier Concordet , Peggy Gandia , Jean-Louis Montastruc , Alain Bousquet‐mélou , Peter Lees et al.
Clinical Pharmacokinetics, 2020, ⟨10.1007/s40262-019-00812-x⟩
Article dans une revue hal-02624662 v1
Image document

Authors' Reply to Nicolas: "Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?

Didier Concordet , Peggy Gandia , Jean-Louis Montastruc , Alain Bousquet‐mélou , Peter Lees et al.
Clinical Pharmacokinetics, 2020, ⟨10.1007/s40262-019-00851-4⟩
Article dans une revue hal-02627433 v1
Image document

Comparing ultrafiltration and equilibrium dialysis to measure unbound plasma dolutegravir concentrations based on a design of experiment approach

David Metsu , Thomas Lanot , François Fraissinet , Didier Concordet , Véronique V. Gayrard-Troy et al.
Scientific Reports, 2020, 10 (1), ⟨10.1038/s41598-020-69102-y⟩
Article dans une revue hal-02911804 v1

Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics

Guillaume Martin-Blondel , Stéphanie Ruiz , Marlene Murris , Stanilas Faguer , Véronigue Duhalde et al.
Clinical Infectious Diseases, 2020, 71 (11), pp.2962-2964. ⟨10.1093/cid/ciaa558⟩
Article dans une revue hal-03167732 v1
Image document

Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR)

Romain Guilhaumou , Sihem Benaboud , Youssef Bennis , Claire Dahyot-Fizelier , Eric Dailly et al.
Critical Care, 2019, 23, pp.104. ⟨10.1186/s13054-019-2378-9⟩
Article dans une revue hal-02095159 v1

Comment on: In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients

Sarah Baklouti , Clémence Massip , Camille Mane , Hélène Guet-Revillet , Marlene Murris et al.
Journal of Antimicrobial Chemotherapy, 2019, 74 (10), pp.3122-3123. ⟨10.1093/jac/dkz307⟩
Article dans une revue hal-02625024 v1
Image document

Authors' Reply to Coste et al.:"Levothyrox New and Old Formulations: Are they Switchable for Millions of Patients?

Didier Concordet , Peggy Gandia , Jean-Louis Montastruc , Alain Bousquet‐mélou , Peter Lees et al.
Clinical Pharmacokinetics, 2019, 58 (7), pp.967-968. ⟨10.1007/s40262-019-00780-2⟩
Article dans une revue hal-02623560 v1
Image document

Authors' Reply to Lechat et al.: " New and Old Formulations: Are they Switchable for Millions of Patients?

Didier Concordet , Peggy Gandia , Jean-Louis Montastruc , Alain Bousquet‐mélou , Peter Lees et al.
Clinical Pharmacokinetics, 2019, 58 (10), pp.1353-1354. ⟨10.1007/s40262-019-00815-8⟩
Article dans une revue hal-02619071 v1

Suicide Attempts

Juliette Salles , Bernard Tiret , Adeline Gallini , Peggy Gandia , Christophe Arbus et al.
Suicide and Life-Threatening Behavior, 2019, 50 (1), pp.315-328. ⟨10.1111/sltb.12586⟩
Article dans une revue hal-03464218 v1
Image document

Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?

Didier Concordet , Peggy Gandia , Jean-Louis Montastruc , Alain Bousquet‐mélou , Peter Lees et al.
Clinical Pharmacokinetics, In press, 58 (7), pp.827-833. ⟨10.1007/s40262-019-00747-3⟩
Article dans une revue hal-02095017 v1
Image document

Authors'Reply to Castello-Bridoux et al.:"Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?

Didier Concordet , Peggy Gandia , Jean-Louis Montastruc , Alain Bousquet‐mélou , Peter Lees et al.
Clinical Pharmacokinetics, 2019, 58 (7), pp.973-975. ⟨10.1007/s40262-019-00786-w⟩
Article dans une revue hal-02627694 v1

Author's Reply to Trechot: "Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?

Didier Concordet , Peggy Gandia , Jean-Louis Montastruc , Alain Bousquet‐mélou , Peter Lees et al.
Clinical Pharmacokinetics, 2019, 58 (7), pp.979-980. ⟨10.1007/s40262-019-00787-9⟩
Article dans une revue hal-02619069 v1

HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy.

Claire Guerveno , Stéphanie Raymond , David Metsu , Peggy Gandia , Jacques Izopet et al.
AIDS. Official journal of the international AIDS Society, 2019, 33 (3), pp.593-594. ⟨10.1097/QAD.0000000000002089⟩
Article dans une revue hal-02618284 v1
Image document

Pourquoi, comment et où dose-t-on les antihypertenseurs en 2019 ?

Beatrice Bouhanick , Pauline Fonquernie , India Bedue , Anaïs Schavgoulidze , Peggy Gandia
Thérapie, 2019, 74 (6), pp.651-664. ⟨10.1016/j.therap.2019.05.002⟩
Article dans une revue hal-02624869 v1

Refining the therapeutic range of posaconazole and isavuconazole for efficient therapeutic drug monitoring using a bioassay approach

Théo Willeman , Julia Tonini , Cécile Garnaud , Sébastien Bailly , Peggy Gandia et al.
Fundamental & Clinical Pharmacology, 2019, ⟨10.1111/fcp.12507⟩
Article dans une revue hal-02976876 v1
Image document

Authors' Reply to Nicolas:"New and Old Formulations: Are they Switchable for Millions of Patients?

Didier Concordet , Peggy Gandia , Jean-Louis Montastruc , Alain Bousquet‐mélou , Peter Lees et al.
Clinical Pharmacokinetics, 2019, 58 (7), pp.961-963. ⟨10.1007/s40262-019-00781-1⟩
Article dans une revue hal-02620199 v1
Image document

Dosage des médicaments antihypertenseurs en France en 2019 et observance.

Beatrice Bouhanick , Bernard Vaïsse , Anaïs Schavgoulidze , Peggy Gandia
La Presse Médicale, 2019, 48 (12), pp.1520-1526. ⟨10.1016/j.lpm.2019.08.009⟩
Article dans une revue hal-02624854 v1

Memory impairment following intentional self-poisoning with benzodiazepines

Juliette Salles , Jérémie Pariente , Laurent Schmitt , Dominique Lauque , Thomas Lanot et al.
Journal of Psychopharmacology, 2019, 33 (11), pp.1428-1435. ⟨10.1177/0269881119867609⟩
Article dans une revue hal-03641012 v1

Efavirenz and lopinavir levels in HIV-infected women and their nursing infants, in Mali

Aboubacar Alassane Oumar , Kadiatou Bagayoko-Maiga , Aliou Bahachimi , Mamoudou Maiga , Marie-Christine Cere et al.
Journal of Pharmacology and Experimental Therapeutics, 2018, 366 (3), pp.479-484. ⟨10.1124/jpet.118.249938⟩
Article dans une revue hal-02625041 v1
Image document

Isavuconazole Kinetic Exploration for Clinical Practice.

Léa Darnaud , Fabien Lamoureux , Cendrine Godet , Sandrine Pontier , Alexia Debard et al.
Drugs in R&D, 2018, 18 (4), pp.317-321. ⟨10.1007/s40268-018-0251-y⟩
Article dans une revue hal-02628582 v1
Image document

Determination of dolutegravir's unbound fraction in human plasma using validated equilibrium dialysis and LC-MS/MS methods

David Metsu , Thomas Lanot , François Fraissinet , Mélanie Picot , Didier Concordet et al.
Clinica Chimica Acta, 2018, 479, pp.56-65. ⟨10.1016/j.cca.2017.12.034⟩
Article dans une revue hal-02621511 v1

Pharmacokinetics of teicoplanin in a breastfeeding mother

François Fraissinet , Marine Lesourd , Nicolas Naudoux , David Metsu , Peggy Gandia
Breastfeeding Medicine, 2017, 12 (4), pp.244-246. ⟨10.1089/bfm.2017.0016⟩
Article dans une revue hal-01600682 v1

Population pharmacokinetics of tracers: A new tool for medical imaging?

Peggy Gandia , Cyril Jaudet , Etienne Chatelut , Didier Concordet
Clinical Pharmacokinetics, 2017, 56 (2), pp.101-106. ⟨10.1007/s40262-016-0437-9⟩
Article dans une revue hal-01607048 v1

Population pharmacokinetic approach applied to positron emission tomography: Computed tomography for tumor tissue identification in patients with glioma

Peggy Gandia , Cyril Jaudet , Hendrik Everaert , Johannes Heemskerk , Anne Marie Vanbinst et al.
Clinical Pharmacokinetics, 2017, 56 (8), pp.953-961. ⟨10.1007/s40262-016-0490-4⟩
Article dans une revue hal-01601882 v1

Is the unbound concentration of atazanavir of interest in therapeutic drug monitoring?

David Metsu , Patrick Séraissol , Pierre Delobel , Christel Cinq-Frais , Lise Cuzin et al.
Fundamental & Clinical Pharmacology, 2017, ⟨10.1111/fcp.12245⟩
Article dans une revue hal-01907438 v1

Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle?

David Metsu , Pierre-Louis Toutain , Etienne Chatelut , Pierre Delobel , Peggy Gandia
Journal of Antimicrobial Chemotherapy, 2017, 72 (9), pp.2407-2409. ⟨10.1093/jac/dkx176⟩
Article dans une revue hal-01608734 v1

Quinine unbound concentration is the best marker for therapeutic drug monitoring.

Carlos de Pablos-Martinez , Lydie Porte , François Fraissinet , Antoine Berry , Patrick Séraissol et al.
Thérapie, 2016, 71 (5), pp.487-489. ⟨10.1016/j.therap.2016.02.032⟩
Article dans une revue hal-01601653 v1

Quinine unbound concentration has to be used for therapeutic drug monitoring.

Carlos de Pablos-Martinez , Lydie Porte , François Fraissinet , Antoine Berry , Patrick Séraissol et al.
Therapeutic Drug Monitoring, 2016, 38 (4), pp.556-7. ⟨10.1097/FTD.0000000000000304⟩
Article dans une revue hal-02634648 v1

Problèmes et difficultés rencontrés lors de la planification et de l'analyse d'un essai de bioéquivalence.

Pierre-Louis Toutain , Peggy Gandia , Alain Bousquet‐mélou
La Lettre du Pharmacologue, 2014, 28 (2), pp.37-50
Article dans une revue hal-02630493 v1

Inhibition of T-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: PK/PD relationships.

Aurélie Prémaud , Annick Rousseau , Gyasi Johnson , Cindy Canivet , Peggy Gandia et al.
Pharmacological Research, 2011, 63 (5), pp.432-8. ⟨10.1016/j.phrs.2011.01.005⟩
Article dans une revue istex inserm-00926481 v1

Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome.

Franck Saint-Marcoux , V. Guigonis , S. Decramer , P. Gandia , B. Ranchin et al.
Pharmacological Research, 2011, 63 (5), pp.423-31. ⟨10.1016/j.phrs.2011.01.009⟩
Article dans une revue istex inserm-00926458 v1
Image document

Modification of aflatoxin B1 and ochratoxin A toxicokinetics in rats administered a yeast cell wall preparation

Stéphane Firmin , Peggy Gandia , Diego Morgavi , Georges Houin , Jp Jouany et al.
Food Additives and Contaminants, 2010, 27 (08), pp.1153-1160. ⟨10.1080/19440041003801174⟩
Article dans une revue hal-00604043 v1

Immediate and delayed hypersensitivity reactions to iodinated radiographic contrast agents: an update.

D. Khachman , Peggy Gandia , Francois Sallerin , Nicolas Mailly
Thérapie, 2009, pp.331-339. ⟨10.2515/therapie/2009040⟩
Article dans une revue istex hal-02665979 v1

Clomipramine in breast milk: a case study

D Khachman , Peggy Gandia , Ma Gaillard , P Seraissol , P Mendousse et al.
Journal de Pharmacie Clinique, 2009, pp.33-38
Article dans une revue hal-02654422 v1

Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome.

Cindy Canivet , Lionel Rostaing , Sylvain Galvani , Torsten Böhler , Peggy Gandia et al.
International Immunopharmacology, 2009, 9 (9), pp.1131-6. ⟨10.1016/j.intimp.2009.05.004⟩
Article dans une revue istex inserm-00410375 v1

Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome

Cindy Canivet , Lionel Rostaing , Sylvain Galvani , Torsten Böhler , Peggy Gandia et al.
International Immunopharmacology, 2009, 9 (9), pp.1131-1136. ⟨10.1016/j.intimp.2009.05.004⟩
Article dans une revue istex hal-02352459 v1

Transfer of benzodiazepines into breast milk: clinical and analytical aspects

D Khachman , Peggy Gandia , F Sena , C Tortissier , P Seraissol et al.
Annales de Toxicologie Analytique, 2008, pp.165-179
Article dans une revue hal-02661242 v1

Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose.

Nassim Kamar , Isabelle Gennero , Luciana Spataru , Laure Esposito , Joelle Guitard et al.
Nephrology Dialysis Transplantation, 2008, 23 (11), pp.3720-6. ⟨10.1093/ndt/gfn345⟩
Article dans une revue istex inserm-00409076 v1

Oral absorption of ampicillin: role of paracellular route vs. PepT1 transporter.

Guylène Lafforgue , Cécile Arellano , Christelle Vachoux , John Woodley , Claude Philibert et al.
Fundamental & Clinical Pharmacology, 2008, 22 (2), pp.189-201. ⟨10.1111/j.1472-8206.2008.00572.x⟩
Article dans une revue istex hal-00517537 v1

Exploring of primary brains tumor heterogeneity at a voxel level with dynamic 18F-fluoro-ethyl-tyrosine (18F-FET) positon emission tomography

Cyril Jaudet , Peggy Gandia , Henrik Everaert , Rémi Servien , J.W. Heemskerk et al.
Congress of the Radiological Sociey of North-America (RSNA), Nov 2015, Chicago, United States. pp.NM219-SD-TUA8
Communication dans un congrès hal-03277832 v1

Pharmacokinetic-Pharmacogenetic exploration of patients presenting unexpected high levels of isavuconazole

L. Darnaud , F. Lamoureux , C. Godet , S. Pontier , A. Debard et al.
Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, Jun 2018, Toulouse, France. Wiley-Blackwell, Fundamental and Clinical Pharmacology, 32, pp.1, 2018, Special Issue: Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting
Poster de conférence hal-02734081 v1

Unexpected low plasma levels of posaconazole with the gastro-resistant tablet: influence of pre-analytical conditions

C Mane , L Darnaud , Didier Concordet , Peggy Gandia
Annual Meeting of French Society of Pharmacology and Therapeutics and INSERM Clinical Research Centers Meeting ; Toulouse (France) - (2018-06-12 - 2018-06-14) / Rencontres, Jun 2018, Toulouse, France. Fundamental and Clinical Pharmacology, 32, 2018
Poster de conférence hal-02734860 v1

Intoxication with baclofen: is haemodialysis indicated?

P. Gandia , S. Girod-Fullana , P. L. Toutain , E. Bertrand , Didier Concordet et al.
Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, Jun 2018, Toulouse, France. Wiley-Blackwell, Fundamental and Clinical Pharmacology, 32, 2018, Special Issue: Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting
Poster de conférence hal-02734668 v1

Influence of ribavirin plasma concentration on the virological response and safety in patients with HCV genotype 1 infection treated by combination therapy with telaprevir or boceprevir

Marie Julia , Peggy Gandia , Mathieu Guivarch , Laura Coimet-Berger , Florence Abravanel et al.
The 65th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2014, Nov 2014, Boston, United States.
Poster de conférence hal-03266134 v1
Image document

Modification of aflatoxin B1 and ochratoxin A toxicokinetics in rats by a yeast cell wall preparation

Stéphane Firmin , P. Gandia , Diego Morgavi , J Pierre Jouany , G. Houin et al.
World Mycotoxin Reduction in Food and Feed Chains, Sep 2009, Tulln, Australia. 2009
Poster de conférence hal-02758381 v1

Etudes pharmacocinétiques durant le développement clinique d'un médicament

E. Chatelut , P. Gandia
Pharmacocinétique: les fondamentaux, EDIMARK SAS, 2018, 978-2-915968-56-9
Chapitre d'ouvrage hal-02786282 v1

Essais Cliniques de phase 1

E. Chatelut , P. Gandia
Pharmacocinétique: les fondamentaux, EDIMARK SAS, 2018, 978-2-915968-56-9
Chapitre d'ouvrage hal-02786293 v1